emerging glp-1 gip treatments 2025 From evidence to action: WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults GLP-1 Trends June 2025: Why

Diminished macrophage apoptosis and reactive oxygen species generation after phorbol ester stimulation in Crohns disease

The platform emphasizes lifestyle integration, ongoing weight tracking, and monthly check-ins

Intravenous vitamin C in the treatment of allergies: an interim subgroup analysis of a long-term observational study

GLP-1s are not miracle drugs for two reasons But theres a key difference between GLP-1s and historic miracle drugs such as penicillin or the polio vaccine

The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy

What research is needed to clarify GHK-Cus role in reproductive health